Human Genome Epidemiology Literature Finder
|
Records 1 - 13 (of 13 Records) |
| Query Trace: Nausea and CYP3A4[original query] |
|---|
| A dose-ranging study of the pharmacokinetics and pharmacodynamics of the selective apoptotic antineoplastic drug (SAAND), OSI-461, in patients with advanced cancer, in the fasted and fed state. Cancer chemotherapy and pharmacology 2009 Feb 63 (3): 477-89. O'Bryant C L, Lieu C H, Leong S, Boinpally R, Basche M, Gore L, Leonardi K, Schultz M K, Hariharan S, Chow L, Diab S, Gibbs A, Eckhardt S |
| Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study. European journal of clinical pharmacology 2012 Jan 68 (1): 55-64. Andreassen Trine Naalsund, Eftedal Ingrid, Klepstad Pål, Davies Andrew, Bjordal Kristin, Lundström Staffan, Kaasa Stein, Dale O |
| Genetic polymorphisms in the three malaysian races effect granisetron clinical antiemetic actions in breast cancer patients receiving chemotherapy. Asian Pacific journal of cancer prevention : APJCP 2011 12 (1): 185-91. Hassan Bassam Abdul Rasool, Yusoff Zuraidah Binti Mo |
| Role of pharmacogenetics on adjuvant chemotherapy-induced neutropenia in Chinese breast cancer patients. Journal of cancer research and clinical oncology 2013 Mar 139 (3): 419-27. Tang Nelson L S, Liao Chen Di, Wang Xingyan, Mo Frankie K F, Chan Vicky T C, Ng Rita, Pang Elizabeth, Suen Joyce J S, Woo Jean, Yeo Winn |
| Effect of CYP3A4*18B polymorphisms and interactions with OPRM1 A118G on postoperative fentanyl requirements in patients undergoing radical gastrectomy. Molecular medicine reports 2013 Jan . Liao Q, Chen DJ, Zhang F, Li L, Hu R, Tang YZ, Ou-Yang W, Huang D |
| Polymorphisms in CYP1A1 and CYP3A5 Genes Contribute to the Variability in Granisetron Clearance and Exposure in Pregnant Women with Nausea and Vomiting. Pharmacotherapy 2016 Nov . Bustos Martha L, Zhao Yang, Chen Huijun, Caritis Steve N, Venkataramanan Ram |
| Does co-administration of paroxetine change oxycodone analgesia: An interaction study in chronic pain patients. Scandinavian journal of pain 2017 Dec 1 (1): 24-33. Lemberg K K, Heiskanen T E, Neuvonen M, Kontinen V K, Neuvonen P J, Dahl M-L, Kalso E |
| A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 4 24 (14): 3253-3262. Bendell Johanna C, Varghese Anna M, Hyman David M, Bauer Todd M, Pant Shubham, Callies Sophie, Lin Ji, Martinez Ricardo, Wickremsinhe Enaksha, Fink Aaron, Wacheck Volker, Moore Kathleen |
| Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers. Basic & clinical pharmacology & toxicology 2018 Jan . Belmonte Carmen, Ochoa Dolores, Román Manuel, Saiz-Rodríguez Miriam, Wojnicz Aneta, Gómez-Sánchez Clara Isabel, Martín-Vílchez Samuel, Abad-Santos Francis |
| Association Study Among Candidate Genetic Polymorphisms and Chemotherapy-Related Severe Toxicity in Testicular Cancer Patients. Frontiers in pharmacology 2019 10 206. Lavanderos María A, Cayún Juan P, Roco Ángela, Sandoval Christopher, Cerpa Leslie, Rubilar Juan C, Cerro Roberto, Molina-Mellico Sebastián, Celedón Cesar, Cerda Berta, García-Martín Elena, Agúndez José A G, Acevedo Cristián, Peña Karina, Cáceres Dante D, Varela Nelson M, Quiñones Luis |
| Effects of pharmacogenetic variants on vemurafenib-related toxicities in patients with melanoma. Pharmacogenomics 2019 12 20 (18): 1283-1290. Goey Andrew Kl, With Mirjam de, Agema Bram C, Hoop Esther Oomen-De, Singh Rajbir K, van der Veldt Astrid Am, Mathijssen Ron Hj, van Schaik Ron Hn, Bins Sand |
| The Effect of Genetic Variation on the Sensitivity to Opioid Analgesics in Patients With Postoperative Pain: An Updated Meta-analysis. Pain physician 2023 9 26 (5): E467-E485. Zhi-Xue Li, Feng Ye, Wen-Yao Li, Yan-Ping Bao, Yin-Chu Cheng, Zai-Wei Song, Rong-Sheng Zhao, Zhen-Yu R |
| Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid Cancer. International journal of molecular sciences 2023 3 24 (6): . Cantara Silvia, Dalmiglio Cristina, Marzocchi Carlotta, Sagnella Alfonso, Brilli Lucia, Trimarchi Andrea, Maino Fabio, Valerio Laura, Castagna Maria Graz |
- Page last reviewed:Feb 1, 2024
- Content source: